Gene UBP1 of Saccharomyces Cereuisiae”

Total Page:16

File Type:pdf, Size:1020Kb

Gene UBP1 of Saccharomyces Cereuisiae” THEJOURNAL OF BIOLOGICALCHEMISTRY Vol. 266, No. 18, Issue of June 25, pp. 12021-1’2028,1991 (c) 1991 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. Cloning and Functional Analysisof the Ubiquitin-specific Protease Gene UBP1 of Saccharomyces cereuisiae” (Received for publication, February 5, 1991) John W. Tobias and Alexander Varshavsky From the Departmentof Biology, Massachusetts Instituteof Technology, Cambridge, Massachusetts02139 In eukaryotes, both natural and engineered fusions erone function,in that its transient(cotranslational) covalent of ubiquitin to itself or other proteins are cleaved by association with specific ribosomal proteins promotes the processing proteases after the last (G~Y‘~)residue of assembly of ribosomal subunits (Finley et al., 1989). In vivo ubiquitin. Using the method ofsib selection,and taking acceptors of ubiquitin include chromosomal histones (Bonner advantage of the fact that bacteria such as Escherichia et al., 1988), integral membrane proteins such as the lympho- coli lack ubiquitin-specific enzymes, we have cloned a cyte homing receptor and the growth hormone receptor (Sie- gene, named UBPl, of the yeast Saccharomyces cere- gelman et al., 1986; Leung et al., 1987), actin (Ball et al., visiae that encodes a ubiquitin-specific processing pro- 1987), the intracellular neurofibrillary tangles in a variety of tease. With the exception of polyubiquitin, the UBPl neurodegenerative diseases (Perry et al., 1987; Lowe et al., protease cleaves at the carboxyl terminus of the ubiqui- 1988), the plant regulatory protein phytochrome (Jabben et tin moiety in natural and engineered fusions irrespec- tive of their size or the presence of an amino-terminal al., 1989), the short-livedMATa2 repressor of the yeast ubiquitin extension. These properties of UBPl distin- Saccharomyces cereuisiae (Hochstrasser et al., 1991), and cy- guish it from the previously cloned yeast protease clins, a family of short-lived cell cycle regulators (Glotzer et YUH1, which deubiquitinates relatively short ubiqui- al., 1991). tin fusions but is virtually inactive withlonger fusions Unlike branched Ub-protein conjugates, which are formed such as ubiquitin-&galactosidase. The amino acid se- posttranslationally, linear Ub-protein adducts are formed as quence of the 809-residue UBPl lacks significantsim- the translational products of either natural or engineered ilarities to other known proteins, including the 236- ubiquitin gene fusions. Thus, in S. cereuisiae for example, residue YUHl protease. Null ubpl mutants are viable, ubiquitin is generated exclusively by proteolytic processing of and retain the ability to deubiquitinate ubiquitin-0- precursors in which ubiquitin is joined either to itself, as in galactosidase, indicating that the family of ubiquitin- the linear polyubiquitin protein UBI4, or to unrelated amino specific proteases in yeast is not limited to UBPl and acid sequences, as in the hybrid proteins UBI1-UBI3 (Ozkay- YUH1. nak et al., 1987). In growing yeast cells, ubiquitin is generated from the UBI1-UBI3 precursors whose “tails” are specific ribosomal proteins (Finley et al., 1989). The polyubiquitin (UBI4) gene is dispensable in growing cells but becomes Ubiquitin (Ub),’ a highly conserved 76-residue protein, is essential (as the main supplier of ubiquitin) during stress present in eukaryotic cells either free or covalently joined to (Finley et al., 1987, 1988). The lack of genes encoding mature a great variety of proteins. The posttranslational coupling of ubiquitin and the fusion structure of ubiquitin precursors in ubiquitin to other proteins is catalyzed by a family of Ub- yeast are characteristic of other eukaryotes as well (Schles- conjugating enzymes (also called E2 enzymes (Pickart and inger and Bond, 1987). Thus, there must exist Ub-specific Rose, 1985)) and involves formation of an isopeptide bond processing proteases that produce ubiquitin, a protein essen- between the carboxyl-terminal glycine residue of ubiquitin tial for cell viability (Finley et al., 1984,1987, 1988), by and the E-amino group of a lysine residue in an acceptor cleaving Gly-X peptide bonds at thejunctions between ubiqui- protein (Pickart, 1988; Jentsch et al., 1990). A major function tin and itscarboxyl-terminal extensions. A priori, these pro- of ubiquitin is to mark proteins destined for selective degra- dation (reviewed by Hershko, 1988; Finley et al., 1988; Cie- teases may also have an isopeptidase activity, i.e. the ability chanover and Schwartz, 1989; Olson and Dice, 1989; Monia to deubiquitinate posttranslationally formed, branched Ub- et al., 1990). Ubiquitin has also been shown to have a chap- protein conjugates. A multiubiquitin chain is one such con- jugate, in which ubiquitin itself serves as an acceptor, with * This work was supported by Grants AGO8991 and DK39520 (to several ubiquitin moieties attached sequentially to the initial A. V.) from the National Institutes of Health. The costs of publication acceptor protein to form a chain of branched Ub-Ub adducts of this article were defrayed in part by the payment of page charges. (Chau et al., 1989). Formation of a multiubiquitin chain on a This article must therefore be hereby marked “aduertisement” in targeted protein is required for the protein’s subsequent deg- accordance with 18 U.S.C. Section 1734 solely to indicate this fact. radation (Chau et al., 1989; Gregori et al., 1990). The nucleotide sequence(s) reportedin thispaper has been submitted tothe GenBankTM/EMBL Data Bunk with accessionnumberls) Ub-specific, ATP-independent proteases capable of cleav- M63484. ing ubiquitin from its linearor branched conjugates have been ’ The abbreviations used are: Ub, ubiquitin; DHFR, dihydrofolate detected in all eukaryotes examined (Matsui et al., 1982; Rose, reductase; UB-X-DHFR, ubiquitin-X-mouse dihydrofolate reductase, 1988; Mayer and Wilkinson, 1989; Jonnalagadda et al., 1989) where X is an amino acid residue at theUb-DHFR junction; Ub-X- but not in bacteria such asEscherichia coli, which lack eukar- Pgal, ubiquitin-X-E. coli (%galactosidase;MTX, methothrexate; SDS- PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis; yotic ubiquitin and Ub-specific enzymes (Finley et al., 1988). DTT, dithiothreitol; LB, Luria broth; HEPES, 4-(2-hydroxyethyl)-l- Recently, Miller et al. (1989) have cloned a S. cereuisiae gene, piperazineethanesulfonic acid; kb, kilobase(s); bp, base pair(s); ORF, named YUHl, for a Ub-specific protease that cleaves ubiqui- open reading frame. tin from its carboxyl-terminal fusions to relatively short 12021 12022 Ubiquitin-specific Protease amino acid sequences but is virtually inactive with larger centrifuge tube containing0.975 mlof 65 mM Na-EDTA, 50 mM Tris- fusions such as Ub-@-galactosidase(Ub-@gal). Wilkinson et HCl (pH 8.0), and protease inhibitors antipain, chymostatin, leupep- al. (1989) havealso cloned a cDNA for a mammalian homolog tin, pepstatin, and aprotinin, each at 25 pg/ml. 10 p1 of 10% (v/v) of the yeast YUHl protease. Triton X-100 was then added and dispersed by pipetting. The lysate was centrifuged at 40,000 X g for 30 min. The supernatant, containing We now report the cloning and functional analysis of an S. the 35S-labeledUb-M-DHFR, was frozen in liquid nitrogen and stored cereuisiue gene, named UBPl, which encodes a Ub-specific at -85 "C. To purify Ub-M-DHFR, a methothrexate (MTX) affinity processing protease whose amino acid sequence is dissimilar matrix was prepared as described by Kaufman (1974), using amino- to those of the YUHl protease and other known proteins. hexyl-Sepharose (Sigma). The MTX-Sepharose column (0.5-ml bed The UBPl protease cleaves at the carboxyl terminus of the volume) was washed with 10 ml of MTX buffer (0.2 M NaCl, 1 mM Na-EDTA, 0.2 mM dithiothreitol (DTT), 20mM Na-HEPES, pH ubiquitin moiety in linear fusions irrespective of their size or 7.5). The Ub-M-DHFR-containing 35Ssupernatant was thawed, clar- the presence of an amino-terminal ubiquitin extension. We ified by centrifugation at 12,000 X g for 1 min, and applied to the also show that null ubpl mutants are viable and have prop- column, which was then washed with 50 ml of MTX buffer, 50 ml of erties indicating that the family of Ub-specific proteases in MTX buffer containing 2M urea, and thenagain with 50 ml of MTX yeast is not limited to UBPl andYUH1. buffer. Ub-M-DHFR was then eluted from the column with folic acid Since Ub-specific proteases cleave ubiquitin from its car- buffer (10 mM folic acid, 1 M KCI, 1 mM DTT, 1 mM Na-EDTA, 0.2 M potassium borate, pH 9.0). The folic acid buffer was applied in 1- boxyl-terminal extensions irrespective of the identity of the ml aliquots, and 1-ml fractions were collected. The fractions were extension's residue abutting the cleavage site (Bachmair et assayed for 35S;pooled fractions containing the peak of 35Swere al., 1986; Gonda et al., 1989), UBPl and its functional coun- dialyzed for 20 h at 4 "C against two changes of storage buffer (50% terparts make possible the in vivo or in vitro generation of glycerol, 1 mM MgCI2, 0.1 mM Na-EDTA, 40 mM Na-HEPES, pH proteins (including short polypeptides) bearing predetermined 7.5), and stored at -20 "C. The purified [35S]Ub-M-DHFRwas as- residues at their amino termini, a method with applications sayed by SDS-PAGE and fluorography and found to be greater than 95% pure. Other test proteins such as DHFR-Ub-M-pgal (Fig. L4, in both basic research (Baker and Varshavsky, 1991; Bartel VI), and the natural yeast ubiquitin fusions UBI2 (Fig. L4, I), UBI3 et al., 1990; Johnson et al., 1990; Townsend et al., 1988) and (Fig. lA, II), and UBI4 (polyubiquitin; Fig. lA, III), were expressed biotechnology (Lu et al., 1990; Butt et al., 1989; Sabin et al., in E. coli and assayed for deubiquitination with UBPl in mixed E. 1989; Ecker et al., 1989; Yo0 et al., 1989; Mak et al., 1989).
Recommended publications
  • Analysis of Gene Expression Data for Gene Ontology
    ANALYSIS OF GENE EXPRESSION DATA FOR GENE ONTOLOGY BASED PROTEIN FUNCTION PREDICTION A Thesis Presented to The Graduate Faculty of The University of Akron In Partial Fulfillment of the Requirements for the Degree Master of Science Robert Daniel Macholan May 2011 ANALYSIS OF GENE EXPRESSION DATA FOR GENE ONTOLOGY BASED PROTEIN FUNCTION PREDICTION Robert Daniel Macholan Thesis Approved: Accepted: _______________________________ _______________________________ Advisor Department Chair Dr. Zhong-Hui Duan Dr. Chien-Chung Chan _______________________________ _______________________________ Committee Member Dean of the College Dr. Chien-Chung Chan Dr. Chand K. Midha _______________________________ _______________________________ Committee Member Dean of the Graduate School Dr. Yingcai Xiao Dr. George R. Newkome _______________________________ Date ii ABSTRACT A tremendous increase in genomic data has encouraged biologists to turn to bioinformatics in order to assist in its interpretation and processing. One of the present challenges that need to be overcome in order to understand this data more completely is the development of a reliable method to accurately predict the function of a protein from its genomic information. This study focuses on developing an effective algorithm for protein function prediction. The algorithm is based on proteins that have similar expression patterns. The similarity of the expression data is determined using a novel measure, the slope matrix. The slope matrix introduces a normalized method for the comparison of expression levels throughout a proteome. The algorithm is tested using real microarray gene expression data. Their functions are characterized using gene ontology annotations. The results of the case study indicate the protein function prediction algorithm developed is comparable to the prediction algorithms that are based on the annotations of homologous proteins.
    [Show full text]
  • New Approaches to Functional Process Discovery in HPV 16-Associated Cervical Cancer Cells by Gene Ontology
    Cancer Research and Treatment 2003;35(4):304-313 New Approaches to Functional Process Discovery in HPV 16-Associated Cervical Cancer Cells by Gene Ontology Yong-Wan Kim, Ph.D.1, Min-Je Suh, M.S.1, Jin-Sik Bae, M.S.1, Su Mi Bae, M.S.1, Joo Hee Yoon, M.D.2, Soo Young Hur, M.D.2, Jae Hoon Kim, M.D.2, Duck Young Ro, M.D.2, Joon Mo Lee, M.D.2, Sung Eun Namkoong, M.D.2, Chong Kook Kim, Ph.D.3 and Woong Shick Ahn, M.D.2 1Catholic Research Institutes of Medical Science, 2Department of Obstetrics and Gynecology, College of Medicine, The Catholic University of Korea, Seoul; 3College of Pharmacy, Seoul National University, Seoul, Korea Purpose: This study utilized both mRNA differential significant genes of unknown function affected by the display and the Gene Ontology (GO) analysis to char- HPV-16-derived pathway. The GO analysis suggested that acterize the multiple interactions of a number of genes the cervical cancer cells underwent repression of the with gene expression profiles involved in the HPV-16- cancer-specific cell adhesive properties. Also, genes induced cervical carcinogenesis. belonging to DNA metabolism, such as DNA repair and Materials and Methods: mRNA differential displays, replication, were strongly down-regulated, whereas sig- with HPV-16 positive cervical cancer cell line (SiHa), and nificant increases were shown in the protein degradation normal human keratinocyte cell line (HaCaT) as a con- and synthesis. trol, were used. Each human gene has several biological Conclusion: The GO analysis can overcome the com- functions in the Gene Ontology; therefore, several func- plexity of the gene expression profile of the HPV-16- tions of each gene were chosen to establish a powerful associated pathway, identify several cancer-specific cel- cervical carcinogenesis pathway.
    [Show full text]
  • SILAC-Based Quantitative Proteomics Approach to Identify Transcription
    ics om & B te i ro o P in f f o o r l m a Journal of a n t r i Trung et al., J Proteomics Bioinform 2014, 7:3 c u s o J ISSN: 0974-276X Proteomics & Bioinformatics DOI: 10.4172/0974-276X.1000306 Research Article Article OpenOpen Access Access SILAC-Based Quantitative Proteomics Approach to Identify Transcription Factors Interacting with a Novel Cis-Regulatory Element Ngo Tat Trung1,2, Rudolf Engelke1,3 and Gerhard Mittler1* 1Proteomics and Mass Spectrometry, Max Planck Institute of Immunobiology and Epignetics, Freiburg, Germany 2Department of Molecular Biology, Tran Hung Dao University Hospital, Hanoi, Vietnam 3Weill Cornell Medical College in Qatar, Doha, State of Qatar Abstract The motif TMTCGCGANR (M being C or A, R being A or G, and N any nucleotide) called M8 was discovered as a putative cis-regulatory element present in 368 human gene promoters. Of these, 236 (64%) are conserved within promoter sequences of four related organisms: human, mouse, rat and dog. However, transcription factors (TFs) interacting with the M8 motif have not yet been described. We previously reported the use of quantitative proteomics coupled to one-step DNA affinity purification as a means of screening for TFs associated with given functional DNA elements. The procedure is performed in-vitro employing SILAC-labeled nuclear extracts and making use of well-characterized cis-regulatory motifs. Building on that, in this study we have combined our method with statistical analysis to filter out false positive hits from the one-step DNA affinity pull-down experiments. This resulted in the identification of zinc finger BED domain-containing protein 1 (ZBED1), alpha globin transcription factor CP2 (TFCP2), upstream binding protein 1 (UBP) and transcription factor CP2 like 1(TFCP2L1), as specific M8 interacting factors.
    [Show full text]
  • Proteomic Analysis of SUMO1-Sumoylome Changes During Defense 4 Elicitation in Arabidopsis
    bioRxiv preprint doi: https://doi.org/10.1101/2020.08.02.233544; this version posted August 3, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Running Title: SUMO1-substrate identification in plant immunity 2 3 Proteomic analysis of SUMO1-SUMOylome changes during defense 4 elicitation in Arabidopsis 5 6 Kishor D. Ingole1,2 Shraddha K. Dahale1 and Saikat Bhattacharjee1* 7 8 1Laboratory of Signal Transduction and Plant Resistance, UNESCO-Regional Centre for Biotechnology 9 (RCB), NCR Biotech Science Cluster, 3rd Milestone, Faridabad-Gurgaon Expressway, Faridabad- 121 10 001, Haryana, India. 11 12 2Kalinga Institute of Industrial Technology (KIIT) University, Bhubaneswar- 751 024, Odisha, India. 13 14 Author for Correspondence: 15 Saikat Bhattacharjee 16 Tel: (+91) 0129-2848837 17 email: [email protected] 18 19 ORCID 20 Saikat Bhattacharjee: https://orcid.org/0000-0003-1369-7700 21 Kishor D. Ingole: https://orcid.org/0000-0003-1946-6639 22 Shraddha K. Dahale: https://orcid.org/0000-0001-8458-3984 23 24 25 26 27 28 bioRxiv preprint doi: https://doi.org/10.1101/2020.08.02.233544; this version posted August 3, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license.
    [Show full text]
  • Supp Table 6.Pdf
    Supplementary Table 6. Processes associated to the 2037 SCL candidate target genes ID Symbol Entrez Gene Name Process NM_178114 AMIGO2 adhesion molecule with Ig-like domain 2 adhesion NM_033474 ARVCF armadillo repeat gene deletes in velocardiofacial syndrome adhesion NM_027060 BTBD9 BTB (POZ) domain containing 9 adhesion NM_001039149 CD226 CD226 molecule adhesion NM_010581 CD47 CD47 molecule adhesion NM_023370 CDH23 cadherin-like 23 adhesion NM_207298 CERCAM cerebral endothelial cell adhesion molecule adhesion NM_021719 CLDN15 claudin 15 adhesion NM_009902 CLDN3 claudin 3 adhesion NM_008779 CNTN3 contactin 3 (plasmacytoma associated) adhesion NM_015734 COL5A1 collagen, type V, alpha 1 adhesion NM_007803 CTTN cortactin adhesion NM_009142 CX3CL1 chemokine (C-X3-C motif) ligand 1 adhesion NM_031174 DSCAM Down syndrome cell adhesion molecule adhesion NM_145158 EMILIN2 elastin microfibril interfacer 2 adhesion NM_001081286 FAT1 FAT tumor suppressor homolog 1 (Drosophila) adhesion NM_001080814 FAT3 FAT tumor suppressor homolog 3 (Drosophila) adhesion NM_153795 FERMT3 fermitin family homolog 3 (Drosophila) adhesion NM_010494 ICAM2 intercellular adhesion molecule 2 adhesion NM_023892 ICAM4 (includes EG:3386) intercellular adhesion molecule 4 (Landsteiner-Wiener blood group)adhesion NM_001001979 MEGF10 multiple EGF-like-domains 10 adhesion NM_172522 MEGF11 multiple EGF-like-domains 11 adhesion NM_010739 MUC13 mucin 13, cell surface associated adhesion NM_013610 NINJ1 ninjurin 1 adhesion NM_016718 NINJ2 ninjurin 2 adhesion NM_172932 NLGN3 neuroligin
    [Show full text]
  • Neglected Functions of TFCP2/TFCP2L1/UBP1 Transcription Factors May Offer Valuable Insights Into Their Mechanisms of Action
    International Journal of Molecular Sciences Review Neglected Functions of TFCP2/TFCP2L1/UBP1 Transcription Factors May Offer Valuable Insights into Their Mechanisms of Action Agnieszka Taracha, Grzegorz Kotarba and Tomasz Wilanowski * Laboratory of Signal Transduction, Nencki Institute of Experimental Biology of Polish Academy of Sciences, 3 Pasteur St., 02-093 Warsaw, Poland; [email protected] (A.T.); [email protected] (G.K.) * Correspondence: [email protected]; Tel.: +48-22-5892-311 Received: 21 August 2018; Accepted: 19 September 2018; Published: 20 September 2018 Abstract: In recent years, the TFCP2 (transcription factor cellular promoter 2)/TFCP2L1 (TFCP2- like 1)/UBP1 (upstream binding protein 1) subfamily of transcription factors has been attracting increasing attention in the scientific community. These factors are very important in cancer, Alzheimer’s disease, and other human conditions, and they can be attractive targets for drug development. However, the interpretation of experimental results is complicated, as in principle, any of these factors could substitute for the lack of another. Thus, studying their hitherto little known functions should enhance our understanding of mechanisms of their functioning, and analogous mechanisms might govern their functioning in medically relevant contexts. For example, there are numerous parallels between placental development and cancer growth; therefore, investigating the roles of TFCP2, TFCP2L1, and UBP1 in the placenta may help us better understand their functioning in cancer, as is evidenced by the studies of various other proteins and pathways. Our review article aims to call the attention of the scientific community to these neglected functions, and encourage further research in this field.
    [Show full text]
  • A New Synuclein-Transgenic Mouse Model for Early Parkinson's Reveals Molecular Features of Preclinical Disease
    bioRxiv preprint doi: https://doi.org/10.1101/2020.04.04.016642; this version posted April 5, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. A new synuclein-transgenic mouse model for early Parkinson's reveals molecular features of preclinical disease Diana M Hendrickx1,*,#, Pierre Garcia1,2,#, Amer Ashrafi1, Alessia Sciortino1, Kristopher J Schmit1, Heike Kollmus3, Nathalie Nicot4, Tony Kaoma5, Laurent Vallar6, Manuel Buttini1,*,$, Enrico Glaab1,$ 1 Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Belvaux, Luxembourg 2 Laboratoire National de Sant´e(LNS), Neuropathology Unit, Dudelange, Luxembourg 3 Department of Infection Genetics, Helmholtz Centre for Infection Research, Braunschweig, Germany 4 Quantitative Biology Unit, Luxembourg Institute of Health, Strassen, Luxembourg 5 Department of Oncology, Luxembourg Institute of Health, Strassen, Luxembourg 6 Genomics Research Unit, Luxembourg Institute of Health, Luxembourg, Luxembourg * [email protected]; [email protected] # equal contributor $ equal contributor Abstract Understanding Parkinson's disease (PD) in particular in its earliest phases is important for diagnosis and treatment. However, human brain samples are collected post-mortem, reflecting mainly end stage disease. Because brain samples of mouse models can be collected at any stage of the disease process, they are useful to investigate PD progression. Here, we compare ventral midbrain transcriptomics profiles from α-synuclein transgenic mice with a progressive, early PD-like striatum neurodegeneration across different ages using pathway, gene set and network analysis methods.
    [Show full text]
  • Systematic Identification and Validation of Housekeeping And
    horticulturae Article Systematic Identification and Validation of Housekeeping and Tissue-Specific Genes in Allotetraploid Chenopodium quinoa Bing He 1,2,†, Hui Chen 1,†, Pibiao Shi 3, Fengqin Hu 3, Wenjing Song 4, Lin Meng 4,* and Yuanda Lv 3,* 1 Shandong Key Laboratory of Water Pollution Control and Resource Reuse, School of Environmental Science and Engineering, Shandong University, Qingdao 266237, China; [email protected] (B.H.); [email protected] (H.C.) 2 Institute of Germplasm Resources and Biotechnology, Jiangsu Academy of Agricultural Sciences, Nanjing 210014, China 3 Excellence and Innovation Center, Jiangsu Academy of Agricultural Sciences, Nanjing 210014, China; [email protected] (P.S.); [email protected] (F.H.) 4 Tobacco Research Institute, Chinese Academy of Agricultural Sciences, Qingdao 266101, China; [email protected] * Correspondence: [email protected] (L.M.); [email protected] (Y.L.) † These authors contributed equally to this work. Abstract: Quinoa is a gluten-free food crop that contains all the essential amino acids and vitamins. The selection of proper housekeeping and tissue-specific genes is the crucial prerequisite for gene expression analysis using the common approach, real-time quantitative PCR (RT-qPCR). In this study, we identified 40 novel candidate housekeeping genes by the minimum transcript per million (TPM), coefficient of variation (CV) and maximum fold change (MFC) methods and 19 candidate tissue- specific genes by the co-expression network method based on an RNA-seq dataset that included Citation: He, B.; Chen, H.; Shi, P.; 53 stem, leaf, flower and seed samples, as well as additional shoot and root samples under different Hu, F.; Song, W.; Meng, L.; Lv, Y.
    [Show full text]
  • WO 2016/040794 Al 17 March 2016 (17.03.2016) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2016/040794 Al 17 March 2016 (17.03.2016) P O P C T (51) International Patent Classification: AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, C12N 1/19 (2006.01) C12Q 1/02 (2006.01) BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, C12N 15/81 (2006.01) C07K 14/47 (2006.01) DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, (21) International Application Number: KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, PCT/US20 15/049674 MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, (22) International Filing Date: PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, 11 September 2015 ( 11.09.201 5) SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (25) Filing Language: English (84) Designated States (unless otherwise indicated, for every (26) Publication Language: English kind of regional protection available): ARIPO (BW, GH, (30) Priority Data: GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, 62/050,045 12 September 2014 (12.09.2014) US TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, (71) Applicant: WHITEHEAD INSTITUTE FOR BIOMED¬ DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, ICAL RESEARCH [US/US]; Nine Cambridge Center, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, Cambridge, Massachusetts 02142-1479 (US).
    [Show full text]
  • 1 SUPPLEMENTAL DATA Figure S1. Poly I:C Induces IFN-Β Expression
    SUPPLEMENTAL DATA Figure S1. Poly I:C induces IFN-β expression and signaling. Fibroblasts were incubated in media with or without Poly I:C for 24 h. RNA was isolated and processed for microarray analysis. Genes showing >2-fold up- or down-regulation compared to control fibroblasts were analyzed using Ingenuity Pathway Analysis Software (Red color, up-regulation; Green color, down-regulation). The transcripts with known gene identifiers (HUGO gene symbols) were entered into the Ingenuity Pathways Knowledge Base IPA 4.0. Each gene identifier mapped in the Ingenuity Pathways Knowledge Base was termed as a focus gene, which was overlaid into a global molecular network established from the information in the Ingenuity Pathways Knowledge Base. Each network contained a maximum of 35 focus genes. 1 Figure S2. The overlap of genes regulated by Poly I:C and by IFN. Bioinformatics analysis was conducted to generate a list of 2003 genes showing >2 fold up or down- regulation in fibroblasts treated with Poly I:C for 24 h. The overlap of this gene set with the 117 skin gene IFN Core Signature comprised of datasets of skin cells stimulated by IFN (Wong et al, 2012) was generated using Microsoft Excel. 2 Symbol Description polyIC 24h IFN 24h CXCL10 chemokine (C-X-C motif) ligand 10 129 7.14 CCL5 chemokine (C-C motif) ligand 5 118 1.12 CCL5 chemokine (C-C motif) ligand 5 115 1.01 OASL 2'-5'-oligoadenylate synthetase-like 83.3 9.52 CCL8 chemokine (C-C motif) ligand 8 78.5 3.25 IDO1 indoleamine 2,3-dioxygenase 1 76.3 3.5 IFI27 interferon, alpha-inducible
    [Show full text]
  • CREB-Dependent Transcription in Astrocytes: Signalling Pathways, Gene Profiles and Neuroprotective Role in Brain Injury
    CREB-dependent transcription in astrocytes: signalling pathways, gene profiles and neuroprotective role in brain injury. Tesis doctoral Luis Pardo Fernández Bellaterra, Septiembre 2015 Instituto de Neurociencias Departamento de Bioquímica i Biologia Molecular Unidad de Bioquímica y Biologia Molecular Facultad de Medicina CREB-dependent transcription in astrocytes: signalling pathways, gene profiles and neuroprotective role in brain injury. Memoria del trabajo experimental para optar al grado de doctor, correspondiente al Programa de Doctorado en Neurociencias del Instituto de Neurociencias de la Universidad Autónoma de Barcelona, llevado a cabo por Luis Pardo Fernández bajo la dirección de la Dra. Elena Galea Rodríguez de Velasco y la Dra. Roser Masgrau Juanola, en el Instituto de Neurociencias de la Universidad Autónoma de Barcelona. Doctorando Directoras de tesis Luis Pardo Fernández Dra. Elena Galea Dra. Roser Masgrau In memoriam María Dolores Álvarez Durán Abuela, eres la culpable de que haya decidido recorrer el camino de la ciencia. Que estas líneas ayuden a conservar tu recuerdo. A mis padres y hermanos, A Meri INDEX I Summary 1 II Introduction 3 1 Astrocytes: physiology and pathology 5 1.1 Anatomical organization 6 1.2 Origins and heterogeneity 6 1.3 Astrocyte functions 8 1.3.1 Developmental functions 8 1.3.2 Neurovascular functions 9 1.3.3 Metabolic support 11 1.3.4 Homeostatic functions 13 1.3.5 Antioxidant functions 15 1.3.6 Signalling functions 15 1.4 Astrocytes in brain pathology 20 1.5 Reactive astrogliosis 22 2 The transcription
    [Show full text]
  • Functionally Enigmatic Genes: a Case Study of the Brain Ignorome
    Functionally Enigmatic Genes: A Case Study of the Brain Ignorome Ashutosh K. Pandey1*,LuLu1, Xusheng Wang1,2, Ramin Homayouni3, Robert W. Williams1 1 UT Center for Integrative and Translational Genomics and Department of Anatomy and Neurobiology, University of Tennessee Health Science Center, Memphis, Tennessee, United States of America, 2 St. Jude Children’s Research Hospital, Memphis, Tennessee, United States of America, 3 Department of Biological Sciences, Bioinformatics Program, University of Memphis, Memphis, Tennessee, United States of America Abstract What proportion of genes with intense and selective expression in specific tissues, cells, or systems are still almost completely uncharacterized with respect to biological function? In what ways do these functionally enigmatic genes differ from well-studied genes? To address these two questions, we devised a computational approach that defines so-called ignoromes. As proof of principle, we extracted and analyzed a large subset of genes with intense and selective expression in brain. We find that publications associated with this set are highly skewed—the top 5% of genes absorb 70% of the relevant literature. In contrast, approximately 20% of genes have essentially no neuroscience literature. Analysis of the ignorome over the past decade demonstrates that it is stubbornly persistent, and the rapid expansion of the neuroscience literature has not had the expected effect on numbers of these genes. Surprisingly, ignorome genes do not differ from well-studied genes in terms of connectivity in coexpression networks. Nor do they differ with respect to numbers of orthologs, paralogs, or protein domains. The major distinguishing characteristic between these sets of genes is date of discovery, early discovery being associated with greater research momentum—a genomic bandwagon effect.
    [Show full text]